Table of Contents
ISRN Endocrinology
Volume 2013, Article ID 184753, 5 pages
Research Article

Liraglutide Suppresses the Plasma Levels of Active and Des-Acyl Ghrelin Independently of Active Glucagon-Like Peptide-1 Levels in Mice

Department of Lifestyle Medicine, Translational Research Center, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan

Received 23 June 2013; Accepted 14 July 2013

Academic Editors: O. Giampietro and P. Morosini

Copyright © 2013 Katsunori Nonogaki and Marina Suzuki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Katsunori Nonogaki, Miki Hazama, and Noriko Satoh, “Liraglutide Suppresses Obesity and Hyperglycemia Associated with Increases in Hepatic Fibroblast Growth Factor 21 Production in KKA(y) Mice,” Biomed Research International, 2014. View at Publisher · View at Google Scholar
  • Manfredi Rizzo, Maciej Banach, Giuseppe Montalto, Giovanni Li Volti, Nicola Abate, Manisha Chandalia, Ali A Rizvi, Rosaria V Giglio, Dragana Nikolic, Antonella Marino Gammazza, Ignazio Barbagallo, and Esma R Isenovic, “Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study.,” The Journal of clinical endocrinology and metabolism, vol. 100, no. 2, pp. 603–6, 2015. View at Publisher · View at Google Scholar